GlycoMimetics Inc (NASDAQ:GLYC)

24.19
Delayed Data
As of 4:00pm ET
 +0.84 / +3.60%
Today’s Change
3.82
Today|||52-Week Range
26.05
+44.07%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close23.35
Today’s open23.48
Day’s range22.90 - 24.28
Volume501,783
Average volume (3 months)659,699
Market cap$801.8M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-123.88%
Earnings growth (this year)+28.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.91%
P/E ratioNM
Price/Sales7,008.84
Price/Book15.38

Competitors

 Today’s
change
Today’s
% change
AVDLAvadel Pharmaceutica...+0.07+0.89%
IOVAIovance Biotherapeut...+0.50+2.70%
DEPODepomed Inc+0.14+1.89%
SVASinovac Biotech Ltd+0.07+0.86%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$18.5K
Annual profit (last year)-$31.8M
Net profit margin-171,945.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts